Asahi Life Asset Management Co., Ltd. Biomarin Pharmaceutical Inc Transaction History
Asahi Life Asset Management Co., Ltd.
- $165 Million
- Q3 2024
A detailed history of Asahi Life Asset Management Co., Ltd. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Asahi Life Asset Management Co., Ltd. holds 5,470 shares of BMRN stock, worth $346,907. This represents 0.23% of its overall portfolio holdings.
Number of Shares
5,470Holding current value
$346,907% of portfolio
0.23%Shares
7 transactions
Others Institutions Holding BMRN
# of Institutions
635Shares Held
178MCall Options Held
2.01MPut Options Held
1.28M-
Black Rock Inc. New York, NY22.7MShares$1.44 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.3MShares$1.22 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.9MShares$1.2 Billion0.99% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$881 Million0.59% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.5MShares$666 Million0.16% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $11.8B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...